- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05826002
Optimization of a Digital Self-guided Psychological Intervention for Insomnia: A Randomized Factorial Experiment
March 10, 2025 updated by: Martin Kraepelien, Karolinska Institutet
In a previous pilot study, a digital self-guided intervention for insomnia showed preliminary positive effects on insomnia symptoms.
In order to optimize the digital self-guided format, this study will evaluate the added value of three treatment features on treatment engagement and insomnia symptoms.
The participants will be adults with insomnia.
The trial will be a 2x2x2 randomized factorial experiment, where the following features/factors will be manipulated: an optimized graphical user interface (yes or no), an adaptive treatment strategy (yes or no), and daily prompts to use the intervention (yes or no).
The factorial experiment will create 8 equally large groups (1:1:1:1:1:1:1:1), who will receive the different combinations of features.
The main outcome will be the effect on treatment engagement.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
447
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Stockholm, Sweden
- Centre for Psychiatry Research
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- ≥ 18 years of age.
- ≥ 15 points on Insomnia Severity Index.
- Insomnia diagnosis, according to criteria in the Diagnostic and Statistical Manual of mental disorders-5 (somatic/psychiatric comorbidity is allowed).
- Good understanding of the Swedish language.
- No practical obstacles to participate in treatment and assessments.
- Daily access to computer/smart-phone/tablet with Internet access.
- Can receive phone calls and text messages during the study period.
Exclusion Criteria:
- Sleep diseases, such as narcolepsy or sleep apnea.
- Somatic or psychiatric illnesses that either are directly contraindicated for the treatment, require other treatment, or entail symptoms/a functional level making it too difficult to participate in the study.
- Alcohol/drug abuse, or medication with side effects on sleep (however, sleep medication is allowed).
- Working nights or night shifts.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Digital insomnia intervention
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (no).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
|
Active Comparator: Digital insomnia intervention + optimized user interface
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (no).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
|
Active Comparator: Digital insomnia intervention + adaptive treatment strategy
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (no).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
|
Active Comparator: Digital insomnia intervention + optimized user interface, adaptive treatment strategy
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (no).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
|
Active Comparator: Digital insomnia intervention + daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (no), daily prompts (yes).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
|
Active Comparator: Digital insomnia intervention + optimized user interface, daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (no), daily prompts (yes).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
|
Active Comparator: Digital insomnia intervention + adaptive treatment strategy, daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (no), adaptive treatment strategy (yes), daily prompts (yes).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
|
Active Comparator: Digital insomnia intervention + optimized user interface, adaptive treatment strategy, daily prompts
This group receives the following combination of treatment features: optimized graphical user interface (yes), adaptive treatment strategy (yes), daily prompts (yes).
|
A four week digital self-guided intervention for insomnia, with content derived from Cognitive Behavioral Therapy for insomnia, and with a clinical interview before and after the intervention.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Engagement with intervention method
Time Frame: Up to 12 months after treatment
|
Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better
|
Up to 12 months after treatment
|
|
Engagement with intervention method
Time Frame: Immediately after treatment (4 weeks after treatment start)
|
Treatment engagement questionnaire (self-rated study-specific questionnaire), score range 0-21 (0-7 per item), higher is better
|
Immediately after treatment (4 weeks after treatment start)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Insomnia symptoms
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
|
Insomnia Severity Index (self-rated), score range 0-28, lower is better
|
Change from baseline (right before treatment start) up to 12 months after treatment
|
|
Change in Insomnia symptoms
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
Insomnia Severity Index (self-rated), score range 0-28, lower is better
|
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
|
Change in Depression symptoms
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
|
Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better
|
Change from baseline (right before treatment start) up to 12 months after treatment
|
|
Change in Depression symptoms
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
Patient Health Questionnaire-9 (self-rated), score range 0-27, lower is better
|
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
|
Change in Anxiety symptoms
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
|
Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better
|
Change from baseline (right before treatment start) up to 12 months after treatment
|
|
Change in Anxiety symptoms
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
Generalized Anxiety Disorder-7 (self-rated), score range 0-21, lower is better
|
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
|
Change in Life quality
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
|
Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better
|
Change from baseline (right before treatment start) up to 12 months after treatment
|
|
Change in Life quality
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
Brunnsviken Brief Quality of life scale (self-rated), score range 0-96, higher is better
|
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
|
Change in Daily function
Time Frame: Change from baseline (right before treatment start) up to 12 months after treatment
|
World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better
|
Change from baseline (right before treatment start) up to 12 months after treatment
|
|
Change in Daily function
Time Frame: Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
World Health Organization Disability Assessment Schedule (self-rated), score rang 0-100, lower is better
|
Change from baseline (right before treatment start) to immediately after treatment (4 weeks after treatment start)
|
|
Treatment credibility
Time Frame: 2 weeks after treatment start (mid-treatment)
|
Credibility/Expectancy Questionnaire (self-rated), score range 0-50, higher is better
|
2 weeks after treatment start (mid-treatment)
|
|
Intervention/system usability
Time Frame: 2 weeks after treatment start (mid-treatment)
|
System Usability Scale (self-rated), score range 0-100, higher is better
|
2 weeks after treatment start (mid-treatment)
|
|
Treatment satisfaction
Time Frame: Immediately after treatment (4 weeks after treatment start)
|
Client Satisfaction Questionnaire-8 (self-rated), score range 8-32, higher is better
|
Immediately after treatment (4 weeks after treatment start)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinician time
Time Frame: Immediately after treatment (4 weeks after treatment start)
|
Time in minutes the clinician spends on the participant giving guidance through telephone calls and/or written guidance, in minutes, lower is better
|
Immediately after treatment (4 weeks after treatment start)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2023
Primary Completion (Actual)
December 15, 2024
Study Completion (Actual)
December 15, 2024
Study Registration Dates
First Submitted
March 27, 2023
First Submitted That Met QC Criteria
April 11, 2023
First Posted (Actual)
April 24, 2023
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
March 10, 2025
Last Verified
March 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-07226-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
IPD available anonymized on reasonable request.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteNot yet recruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
University of California, San FranciscoCompleted
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
NYU Langone HealthNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedInsomniaUnited States
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
Eisai Inc.CompletedInsomniaUnited States
-
SanofiCompletedInsomniaUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
Clinical Trials on Digital self-guided psychological intervention for insomnia
-
Northwestern UniversityCompletedDepression | Anxiety | Suicidal Ideation | Nonsuicidal Self InjuryUnited States
-
Karolinska InstitutetRegion StockholmCompletedIllness Anxiety Disorder | Somatic Symptom DisorderSweden
-
Karolinska InstitutetRegion StockholmCompletedInsomnia | Major Depression | Minor DepressionSweden
-
Ottawa Hospital Research InstituteThe Ottawa HospitalCompletedChronic Pain | InsomniaCanada
-
Yale UniversityNational Institute of Nursing Research (NINR); Milton S. Hershey Medical CenterCompletedHeart Failure | Pain | Fatigue | Sleep Initiation and Maintenance Disorders | Anxiety | Depressive Symptoms | Congestive Heart Failure | Sleep Disorders | Chronic Insomnia | Heart Failure, Congestive | Cardiac Failure | Disorders of Initiating and Maintaining SleepUnited States
-
Karolinska InstitutetStockholm RegionCompleted
-
University College CorkCompletedInsomnia | Sleep | Dementia | Mild Cognitive ImpairmentIreland
-
Peking University First HospitalShenzhen Zeen Health Technology Co., Ltd.Recruiting
-
Karolinska InstitutetRegion StockholmCompleted
-
Karolinska InstitutetKarolinska University HospitalCompleted